AB 2186 amends Section 4067 of the Business and Professions Code with a nonsubstantive change to the statutory text governing internet dispensing of dangerous drugs and devices. The bill does not add new policy obligations or remove existing enforcement authorities; it adjusts wording and punctuation in the statute.
The practical effect is drafting-level: compliance obligations, the board’s enforcement powers, the Attorney General’s authority to sue and collect penalties, and the Franchise Tax Board offset mechanism remain governed by the existing statute. Licensed pharmacists, online dispensers, and counsel should treat this as a clarifying edit but note that any future litigation could treat small drafting changes as relevant to statutory interpretation.
At a Glance
What It Does
AB 2186 revises the wording of B&P Code §4067 (internet dispensing) — primarily singular/plural and punctuation adjustments — and leaves the existing standards and cross-references intact. It does not modify the substantive rule that dispensing dangerous drugs or devices over the internet requires a prescription issued after an appropriate prior examination, nor does it change the penalty structure.
Who It Affects
Licensed pharmacists and pharmacies that dispense or ship prescriptions into California, online-only pharmacies and telepharmacy services, the California State Board of Pharmacy and its enforcement staff, and legal counsel who advise regulated entities on compliance and risk.
Why It Matters
Even technical statutory edits can affect enforcement contests and administrative interpretation; lawyers and compliance officers should update internal citations and drafting templates, confirm consistency with Title 16 §1761 regulations, and watch for any administrative guidance interpreting the amended text.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
Section 4067 prohibits dispensing or furnishing “dangerous drugs” or “dangerous devices” over the internet for delivery to anyone in California unless the prescription was issued following an appropriate prior examination of the human or animal patient. The bill itself makes only a drafting change to that sentence (adjusting singular/plural forms and punctuation) and leaves the substantive condition—an appropriate prior exam—unchanged.
The provision ties compliance to existing regulatory standards in Title 16, §1761, which set out minimum requirements for online prescribing and counseling.
The statute already authorizes substantial penalties: the board may issue a citation for up to $25,000 per occurrence or seek a civil penalty of $25,000 per occurrence. The Attorney General can bring enforcement actions to collect those amounts.
The law also provides a practical collection mechanism: after a final judgment, the Franchise Tax Board may offset tax refunds or lottery winnings of a defendant to satisfy fines and then forward the funds to the Pharmacy Board Contingent Fund.Other clauses in §4067 preserve the board’s full scope: the section does not permit unlicensed practice of pharmacy and does not limit the board’s authority to enforce other provisions of the Pharmacy Law. The statute defines “appropriate prior examination” by reference to standards that apply to physicians (Section 2242) and veterinarians (Section 4826.6), which means the legal duty to verify an exam’s adequacy sits with both the prescriber and the dispenser when prescriptions cross state lines or are issued via telemedicine modalities.Because AB 2186 is a non-substantive amendment, it does not change who bears risk under §4067 or the available penalties.
What does change is the text courts and regulators will read; that matters for narrow rules of statutory interpretation, cross-reference clarity, and compliance documentation. Practitioners should update policies and citations but should not expect any immediate change in enforcement practice solely from this bill.
The Five Things You Need to Know
AB 2186 makes a nonsubstantive wording edit to B&P Code §4067; it does not change duties, penalties, or enforcement authorities.
§4067 makes it unlawful to dispense dangerous drugs or devices over the internet for delivery in California unless the prescription follows an “appropriate prior examination.”, The statute authorizes up to $25,000 per occurrence either by board citation or as a civil penalty, and the Attorney General can sue to collect those fines.
After a final judgment, the Franchise Tax Board may offset a defendant’s tax refunds or lottery winnings to satisfy civil penalties and forward proceeds to the Pharmacy Board Contingent Fund.
“Appropriate prior examination” in §4067 explicitly incorporates the standards for physicians (Section 2242) and veterinarians (Section 4826.6), tying online prescribing to existing medical and veterinary examination rules.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Internet-dispensing prohibition and cross-reference to Title 16 regulations
Subdivision (a) is the operative prohibition: a person or entity may not dispense dangerous drugs or devices via the internet for delivery in California without a prescription issued after an appropriate prior exam. It also conditions liability on knowledge (knew or reasonably should have known) that the prescription lacked an appropriate prior exam, and it ties compliance to the requirements in Title 16, §1761. Practically, this mixes objective standards (a triggering regulatory cross-reference) with a negligence-style knowledge qualifier, which affects how investigators and courts assess culpability for online dispensers.
Penalty mechanics: citations and civil penalties
Subdivision (b) preserves the statute’s twin penalty tracks: the board may impose a citation of up to $25,000 per occurrence, or a civil penalty of $25,000 per occurrence. That per-occurrence framing creates high exposure for repeated or batch violations (for example, each improper shipment could be a separate occurrence) and gives the board flexibility to choose administrative or civil enforcement routes.
Attorney General enforcement authority
Subdivision (c) authorizes the Attorney General to bring actions to enforce §4067 and to collect penalties. This centralizes high-stakes enforcement at the state level rather than leaving all collection to administrative processes, and it increases the potential for civil litigation involving out-of-state entities that ship into California.
Collection via Franchise Tax Board offset
Subdivision (d) operationalizes collection: upon final judgment, the Attorney General or the board notifies the Franchise Tax Board, which can offset the defendant’s tax refunds or lottery winnings and forward recovered amounts to the Pharmacy Board Contingent Fund. That mechanism tightens enforcement by creating a practical collection tool that bypasses some difficulties of cross-jurisdiction debt collection.
Preservation of board authority and definition of ‘appropriate prior examination’
Subdivision (e) makes clear the section does not legalize unlicensed practice or limit other board powers, preserving the board’s broader regulatory reach. Subdivision (f) clarifies that “appropriate prior examination” includes the standards found in physician Section 2242 and veterinarian Section 4826.6, linking the pharmacy statute to existing medical and veterinary obligations and embedding professional-examination standards into pharmacy enforcement.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- California patients concerned about unsafe online prescribing — retains a statutory backstop that conditions internet dispensing on an appropriate prior exam, aimed at reducing prescriptions issued without adequate clinical evaluation.
- California State Board of Pharmacy — maintains clear statutory authority and an administrative/civil penalty framework to discipline noncompliant online dispensers.
- State enforcement — Attorney General and Franchise Tax Board benefit from explicit collection powers (AG can sue; FTB can offset refunds), increasing practical recoverability of penalties.
Who Bears the Cost
- Online pharmacies and telepharmacy services — continue to face exposure to per-occurrence $25,000 penalties and must ensure prescribers meet the referenced examination standards.
- Out-of-state prescribers and telemedicine platforms — risk enforcement when prescriptions cross into California if they or their dispensing partners cannot show an adequate prior exam.
- Small telehealth startups and new market entrants — compliance and legal review costs increase because the statute’s strict per-occurrence exposure requires conservative operational controls and recordkeeping.
Key Issues
The Core Tension
The statute seeks to protect patient safety by requiring an appropriate prior exam and by attaching stiff per‑occurrence penalties, but those same strictures can impede legitimate telepharmacy and telemedicine models—creating a trade-off between deterring improper online prescribing and preserving access and innovation in remote care.
Because AB 2186 is explicitly nonsubstantive, the near-term regulatory landscape does not change. The real question is interpretive: minor drafting fixes can matter in close enforcement or litigation fights.
Two parts of §4067 invite particular attention. First, the knowledge standard — “knew or reasonably should have known” — mixes subjective and objective elements.
That hybrid standard gives investigators leverage but creates uncertainty for businesses about what internal controls are sufficient to avoid liability. Second, the per‑occurrence $25,000 exposure can rapidly escalate penalties in cases involving many shipments; policymakers designed a high deterrent, but enforcement discretion and counting rules (what counts as one occurrence) will determine actual risk.
Implementation friction is practical: Title 16, §1761 carries detailed procedural obligations for online prescribing and counseling. Dispensers must reconcile board regs, medical and veterinary examination standards, and inter-jurisdictional telemedicine rules.
The FTB offset mechanism strengthens collections but raises administrative questions about timing, notice to defendants, and the handling of contested adjudications. Finally, while the bill leaves substance intact, counsel should note that text changes sometimes trigger updated administrative interpretations or give plaintiffs narrow openings to press challenges based on statutory drafting.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.